Citigroup Funding (EAK) FWP Free writing prospectus

Citigroup Funding Inc. Pricing Sheet No. 2012—MTNDG0302 dated October 31, 2012 relating to Preliminary Pricing Supplement No. 2012—MTNDG0302 dated September 28, 2012 Registration Statement Nos. 333-172554 and 333-172554-01 Filed Pursuant to Rule 433

322,000 Enhanced Trigger Jump Securities Based on Shares of the iShares® FTSE China 25 Index Fund

Due October 30, 2017

PRICING TERMS – OCTOBER 31, 2012
Shares:	Shares of the iShares® FTSE China 25 Index Fund (the “ETF” or “underlying share issuer”) (NYSE Arca symbol: “FXI”)
Aggregate principal amount:	$3,220,000
Stated principal amount:	$10 per security
Pricing date:	October 31, 2012
Issue date:	November 5, 2012
Valuation date:	October 25, 2017, subject to postponement if such date is not a scheduled trading day or if certain market disruption events occur
Maturity date:	October 30, 2017
Payment at maturity:	For each $10.00 security you hold at maturity: ▪If the final share price is greater than or equal to the trigger price: $10 + the greater of (i) the fixed return amount and (ii) $10 × the share percent change ▪If the final share price is less than the trigger price: $10 × the share performance factor If the final share price is less than the trigger price, your payment at maturity will be less, and possibly significantly less, than $8.00 per security. You should not invest in the securities unless you are willing and able to bear the risk of losing a significant portion of your investment.
Initial share price:	$36.77, the closing price of the shares on the pricing date
Final share price:	The closing price of the shares on the valuation date
Trigger price:	$29.416, 80% of the initial share price
Fixed return amount:	$4.00 per security (40% of the stated principal amount).  You will receive the fixed return amount only if the final share price is greater than or equal to the trigger price.
Share percent change:	(final share price – initial share price) / initial share price
Share performance factor:	final share price / initial share price
Listing:	The securities will not be listed on any securities exchange.
CUSIP / ISIN:	17318Q558 / US17318Q5586
Underwriter:	Citigroup Global Markets Inc., an affiliate of the issuer, acting as principal
Underwriting fee and issue price:	Price to public(1)	Underwriting fee(1)	Proceeds to issuer
Per security:	$10.00	$0.30	$9.70
Total:	$3,220,000	$96,600	$3,123,400

(1) The price to public for a particular investor and the related underwriting fee received by Citigroup Global Markets Inc. may be reduced for volume purchase discounts depending on the aggregate amount of securities purchased by that investor.  The lowest price payable by an investor is $9.90 per security. For information on the distribution of the securities, see “Supplemental Plan of Distribution” in the related preliminary pricing supplement.  In addition to the underwriting fee, Citigroup Global Markets Inc. and its affiliates may profit from expected hedging activity related to this offering, even if the value of the securities declines.  See “Use of Proceeds and Hedging” in the accompanying prospectus.

You should read this document together with the preliminary pricing supplement describing this offering and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below.

Preliminary Pricing Supplement dated September 28, 2012

Product Supplement No. EA-02-01 dated May 21, 2012 Underlying Supplement No. 1 dated May 23, 2012

Prospectus Supplement and Prospectus dated May 12, 2011

The securities are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of, or guaranteed by, a bank.

Citigroup Funding Inc., the issuer, and Citigroup Inc., the guarantor, have filed a registration statement (including a product supplement, underlying supplement, prospectus supplement and prospectus) with the Securities and Exchange Commission (“Commission”) for the offering to which this communication relates. You should read the accompanying product supplement, underlying supplement, prospectus supplement and prospectus in that registration statement (File Nos. 333-172554 and 333-172554-01) and the other documents Citigroup Funding Inc. and Citigroup Inc. have filed with the Commission for more complete information about Citigroup Funding Inc., Citigroup Inc. and this offering. You may get these documents for free by visiting EDGAR on the Commission’s website at www.sec.gov. Alternatively, you can request the accompanying product supplement, underlying supplement, prospectus supplement and prospectus by calling toll-free 1-877-858-5407.